Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients

The emergence of new immunosuppressants, such as the macrolide drug tacrolimus (prograf), has recently become one of the most important advances in transplantology. Tacrolimus belongs to calcineurin inhibitors and differs from cyclosporine in a rapider and uniform bile acid-independent absorption, c...

Full description

Saved in:
Bibliographic Details
Main Authors: O. N. Rzhevskaya, A. V. Pinchuk, R. V. Storozhev, I. V. Dmitriev
Format: Article
Language:English
Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
Series:Трансплантология (Москва)
Subjects:
Online Access:https://www.jtransplantologiya.ru/jour/article/view/255
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850041606094192640
author O. N. Rzhevskaya
A. V. Pinchuk
R. V. Storozhev
I. V. Dmitriev
author_facet O. N. Rzhevskaya
A. V. Pinchuk
R. V. Storozhev
I. V. Dmitriev
author_sort O. N. Rzhevskaya
collection DOAJ
description The emergence of new immunosuppressants, such as the macrolide drug tacrolimus (prograf), has recently become one of the most important advances in transplantology. Tacrolimus belongs to calcineurin inhibitors and differs from cyclosporine in a rapider and uniform bile acid-independent absorption, causing a reduction in the individual variability of the blood concentration of the active ingredient. On renal transplantation in sensitized patients and/or repeated allografting, the use of tacrolimus makes it possible to reduce the percentage of hormone-resistant crises by more than twice and to prevent intractable acute rejection crisis.
format Article
id doaj-art-72669281ad9f424b97895e18fd8fae3a
institution DOAJ
issn 2074-0506
2542-0909
language English
publishDate 2018-08-01
publisher N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
record_format Article
series Трансплантология (Москва)
spelling doaj-art-72669281ad9f424b97895e18fd8fae3a2025-08-20T02:55:45ZengN.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare DepartmentТрансплантология (Москва)2074-05062542-09092018-08-0102515310.23873/2074-0506-2009-0-2-51-53244Use of tacrolimus to prevent acute kidney graft rejection in sensitized patientsO. N. Rzhevskaya0A. V. Pinchuk1R. V. Storozhev2I. V. Dmitriev3N.V. Sklifosovsky Research Institute of Emergency Care; Moscow State University of Medicine and DentistryN.V. Sklifosovsky Research Institute of Emergency Care; Moscow State University of Medicine and DentistryN.V. Sklifosovsky Research Institute of Emergency Care; Moscow State University of Medicine and DentistryN.V. Sklifosovsky Research Institute of Emergency Care; Moscow State University of Medicine and DentistryThe emergence of new immunosuppressants, such as the macrolide drug tacrolimus (prograf), has recently become one of the most important advances in transplantology. Tacrolimus belongs to calcineurin inhibitors and differs from cyclosporine in a rapider and uniform bile acid-independent absorption, causing a reduction in the individual variability of the blood concentration of the active ingredient. On renal transplantation in sensitized patients and/or repeated allografting, the use of tacrolimus makes it possible to reduce the percentage of hormone-resistant crises by more than twice and to prevent intractable acute rejection crisis.https://www.jtransplantologiya.ru/jour/article/view/255allograftingimmunosuppressantscalcineurin inhibitorstacrolimuscyclosporineacute rejection crisis
spellingShingle O. N. Rzhevskaya
A. V. Pinchuk
R. V. Storozhev
I. V. Dmitriev
Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
Трансплантология (Москва)
allografting
immunosuppressants
calcineurin inhibitors
tacrolimus
cyclosporine
acute rejection crisis
title Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
title_full Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
title_fullStr Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
title_full_unstemmed Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
title_short Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
title_sort use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
topic allografting
immunosuppressants
calcineurin inhibitors
tacrolimus
cyclosporine
acute rejection crisis
url https://www.jtransplantologiya.ru/jour/article/view/255
work_keys_str_mv AT onrzhevskaya useoftacrolimustopreventacutekidneygraftrejectioninsensitizedpatients
AT avpinchuk useoftacrolimustopreventacutekidneygraftrejectioninsensitizedpatients
AT rvstorozhev useoftacrolimustopreventacutekidneygraftrejectioninsensitizedpatients
AT ivdmitriev useoftacrolimustopreventacutekidneygraftrejectioninsensitizedpatients